Caligan Partners as of June 30, 2026
Portfolio Holdings for Caligan Partners
Caligan Partners holds 26 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Liquidia Corporation Com New (LQDA) | 30.5 | $647M | 8.1M | 79.73 | |
| Revolution Medicines (RVMD) | 19.5 | $415M | 2.2M | 187.28 | |
| Abivax Sa Sponsored Ads (ABVX) | 9.8 | $208M | 1.6M | 133.26 | |
| Vaxcyte (PCVX) | 6.0 | $127M | 2.2M | 58.13 | |
| Exelixis (EXEL) | 4.0 | $85M | 1.6M | 54.41 | |
| Tango Therapeutics (TNGX) | 3.7 | $78M | 2.5M | 31.26 | |
| Avalo Therapeutics Com New (AVTX) | 2.8 | $59M | 3.2M | 18.48 | |
| Xenon Pharmaceuticals (XENE) | 2.5 | $54M | 890k | 60.36 | |
| Adma Biologics (ADMA) | 2.4 | $50M | 6.0M | 8.37 | |
| Lb Pharmaceuticals Com Shs (LBRX) | 2.2 | $47M | 1.4M | 32.45 | |
| Immunocore Hldgs Ads (IMCR) | 2.1 | $44M | 1.4M | 31.75 | |
| Miragen Therapeutics (VRDN) | 1.9 | $40M | 2.2M | 18.37 | |
| Vor Biopharma Com New (VOR) | 1.7 | $35M | 1.9M | 18.41 | |
| Sab Biotherapeutics Com New (SABS) | 1.5 | $31M | 8.0M | 3.90 | |
| Inventiva Sa Ads (IVA) | 1.5 | $31M | 8.2M | 3.78 | |
| Aura Biosciences (AURA) | 1.4 | $31M | 4.3M | 7.10 | |
| Tyra Biosciences (TYRA) | 1.2 | $26M | 807k | 31.94 | |
| Ocuphire Pharma (IRD) | 1.2 | $25M | 6.1M | 4.11 | |
| Anika Therapeutics (ANIK) | 1.0 | $21M | 1.4M | 14.63 | |
| Sagimet Biosciences Com Ser A (SGMT) | 0.9 | $19M | 2.5M | 7.73 | |
| Artiva Biotherapeutics (ARTV) | 0.8 | $17M | 1.7M | 9.70 | |
| Faeth Therapeutics Com New (FTH) | 0.7 | $16M | 630k | 25.00 | |
| Mbx Biosciences (MBX) | 0.5 | $11M | 200k | 55.20 | |
| Verrica Pharmaceuticals Com Shs (VRCA) | 0.3 | $5.7M | 924k | 6.12 | |
| Agios Pharmaceuticals Call Option (AGIO) | 0.2 | $3.3M | 90k | 37.11 | |
| Cellectar Biosciences Com New (CLRB) | 0.1 | $1.3M | 470k | 2.78 |
